Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059557629> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2059557629 abstract "Several modalities involving a Multiple Daily Fractionation (MDF) course in combination with hyperthermia and/or the hypoxic sensitizer misonidazole have been tested on a mouse tumor system and then applied, with the proper sequencing, to a group of patients with multiple (N2-N3) neck node metastases from H&N cancers. Different lesions of the same patients underwent different modalities. The clinical results indicate the effectiveness, in respect to a historical series of patients treated with conventional fractionation (200 rads/day, five days/week), of either MDF alone (200 + 150 + 150 rads/day, five days/week) or MDF + hyperthermia (500 MHz, 42-43 C, 45 min., after 2nd daily fraction, on day 1, 3, and 5 of each week) or MDF + misonidazole (1.2 g/m2 daily, 2 hours before 1st fraction, up to a maximum dose of 12 g/m2), or MDF + hyperthermia + misonidazole. The latter modality appears to be possibly the most effective at inducing a complete local tumor response lasting longer in time (follow-up to a minimum of four months). The pharmacology of misonidazole has been monitored in the patients to avoid undesired excessive drug plasma level. No neurological symptoms have been observed. Oropharyngeal mucositis has been observed only in patients treated with misonidazole and radiation through two cross-firing portals. The problem of selecting individual patients for a particular modality is discussed." @default.
- W2059557629 created "2016-06-24" @default.
- W2059557629 creator A5021909304 @default.
- W2059557629 creator A5039931761 @default.
- W2059557629 creator A5042324280 @default.
- W2059557629 creator A5058413381 @default.
- W2059557629 creator A5075332996 @default.
- W2059557629 creator A5076959334 @default.
- W2059557629 date "1980-06-01" @default.
- W2059557629 modified "2023-10-06" @default.
- W2059557629 title "Multiple daily fractionation (MDF) radiotherapy in association with hyperthermia and/or misonidazole: Experimental and clinical results" @default.
- W2059557629 cites W1966031020 @default.
- W2059557629 cites W1967446501 @default.
- W2059557629 cites W1971292623 @default.
- W2059557629 cites W1984930994 @default.
- W2059557629 cites W1990071412 @default.
- W2059557629 cites W1993711170 @default.
- W2059557629 cites W2002910462 @default.
- W2059557629 cites W2006545416 @default.
- W2059557629 cites W2011253107 @default.
- W2059557629 cites W2014044319 @default.
- W2059557629 cites W2017766609 @default.
- W2059557629 cites W2029835502 @default.
- W2059557629 cites W2030407171 @default.
- W2059557629 cites W2045826187 @default.
- W2059557629 cites W2053563930 @default.
- W2059557629 cites W2085908637 @default.
- W2059557629 cites W2093558900 @default.
- W2059557629 doi "https://doi.org/10.1002/1097-0142(19800601)45:11<2707::aid-cncr2820451102>3.0.co;2-6" @default.
- W2059557629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7379004" @default.
- W2059557629 hasPublicationYear "1980" @default.
- W2059557629 type Work @default.
- W2059557629 sameAs 2059557629 @default.
- W2059557629 citedByCount "19" @default.
- W2059557629 countsByYear W20595576292021 @default.
- W2059557629 crossrefType "journal-article" @default.
- W2059557629 hasAuthorship W2059557629A5021909304 @default.
- W2059557629 hasAuthorship W2059557629A5039931761 @default.
- W2059557629 hasAuthorship W2059557629A5042324280 @default.
- W2059557629 hasAuthorship W2059557629A5058413381 @default.
- W2059557629 hasAuthorship W2059557629A5075332996 @default.
- W2059557629 hasAuthorship W2059557629A5076959334 @default.
- W2059557629 hasBestOaLocation W20595576291 @default.
- W2059557629 hasConcept C126322002 @default.
- W2059557629 hasConcept C141071460 @default.
- W2059557629 hasConcept C178790620 @default.
- W2059557629 hasConcept C185592680 @default.
- W2059557629 hasConcept C202751555 @default.
- W2059557629 hasConcept C2779949491 @default.
- W2059557629 hasConcept C2781305896 @default.
- W2059557629 hasConcept C2989005 @default.
- W2059557629 hasConcept C3020606620 @default.
- W2059557629 hasConcept C42219234 @default.
- W2059557629 hasConcept C509974204 @default.
- W2059557629 hasConcept C55493867 @default.
- W2059557629 hasConcept C71924100 @default.
- W2059557629 hasConcept C97428945 @default.
- W2059557629 hasConceptScore W2059557629C126322002 @default.
- W2059557629 hasConceptScore W2059557629C141071460 @default.
- W2059557629 hasConceptScore W2059557629C178790620 @default.
- W2059557629 hasConceptScore W2059557629C185592680 @default.
- W2059557629 hasConceptScore W2059557629C202751555 @default.
- W2059557629 hasConceptScore W2059557629C2779949491 @default.
- W2059557629 hasConceptScore W2059557629C2781305896 @default.
- W2059557629 hasConceptScore W2059557629C2989005 @default.
- W2059557629 hasConceptScore W2059557629C3020606620 @default.
- W2059557629 hasConceptScore W2059557629C42219234 @default.
- W2059557629 hasConceptScore W2059557629C509974204 @default.
- W2059557629 hasConceptScore W2059557629C55493867 @default.
- W2059557629 hasConceptScore W2059557629C71924100 @default.
- W2059557629 hasConceptScore W2059557629C97428945 @default.
- W2059557629 hasLocation W20595576291 @default.
- W2059557629 hasLocation W20595576292 @default.
- W2059557629 hasOpenAccess W2059557629 @default.
- W2059557629 hasPrimaryLocation W20595576291 @default.
- W2059557629 hasRelatedWork W2019820853 @default.
- W2059557629 hasRelatedWork W2034978941 @default.
- W2059557629 hasRelatedWork W2094844203 @default.
- W2059557629 hasRelatedWork W2115731235 @default.
- W2059557629 hasRelatedWork W2152021423 @default.
- W2059557629 hasRelatedWork W2159322809 @default.
- W2059557629 hasRelatedWork W219189136 @default.
- W2059557629 hasRelatedWork W2249732560 @default.
- W2059557629 hasRelatedWork W2417339288 @default.
- W2059557629 hasRelatedWork W2428341374 @default.
- W2059557629 isParatext "false" @default.
- W2059557629 isRetracted "false" @default.
- W2059557629 magId "2059557629" @default.
- W2059557629 workType "article" @default.